Thought Leader Select has announced another leadership appointment, as Mark Schoeman has been named General Manager of the company’s Clear Point Health division. 
Clear Point Health is a division of Thought Leader Select, where Schoeman’s research team works with life sciences companies to assess key customer relationships with external stakeholders like key opinion leaders and healthcare professionals. Clear Point Health’s research and insights have empowered several of the world’s largest biopharmaceutical firms to optimize their customer experience on an ongoing basis.
Schoeman began working with Thought Leader Select’s clients in 2012, pioneering multiple breakthrough research products to help medical affairs teams build better external relationships and partnerships and quantify medical affairs divisions’ return on investment to their larger organizations. These products include KOL Beliefs and Preferences Mapping, KOL/MSL Relationship Assessments, and various bespoke products to meet the business optimization needs of multiple global biopharmaceutical firms.
“When I look back on the 17-year history of Thought Leader Select, what I’m most proud of is our history of innovation,” said Paul Meade, TLS founder and President. “We are a people-powered business, and Mark has been one of our leaders at the forefront of developing new methods of capturing the insights our clients need to succeed. Clear Point Health is now a world leader in helping medical affairs divisions become more profitable, more agile, and better meet the needs of their counterparts in the medical community and patients.”
For more information on Clear Point Health’s products for medical affairs optimization, contact Mark Schoeman at mschoeman@clearpointhealth.com.
Schoeman Named General Manager of Clear Point Health
Thought Leader Select has announced another leadership appointment, as Mark Schoeman has been named General Manager of the company’s Clear Point Health division.
Clear Point Health is a division of Thought Leader Select, where Schoeman’s research team works with life sciences companies to assess key customer relationships with external stakeholders like key opinion leaders and healthcare professionals. Clear Point Health’s research and insights have empowered several of the world’s largest biopharmaceutical firms to optimize their customer experience on an ongoing basis.
Schoeman began working with Thought Leader Select’s clients in 2012, pioneering multiple breakthrough research products to help medical affairs teams build better external relationships and partnerships and quantify medical affairs divisions’ return on investment to their larger organizations. These products include KOL Beliefs and Preferences Mapping, KOL/MSL Relationship Assessments, and various bespoke products to meet the business optimization needs of multiple global biopharmaceutical firms.
“When I look back on the 17-year history of Thought Leader Select, what I’m most proud of is our history of innovation,” said Paul Meade, TLS founder and President. “We are a people-powered business, and Mark has been one of our leaders at the forefront of developing new methods of capturing the insights our clients need to succeed. Clear Point Health is now a world leader in helping medical affairs divisions become more profitable, more agile, and better meet the needs of their counterparts in the medical community and patients.”
For more information on Clear Point Health’s products for medical affairs optimization, contact Mark Schoeman at mschoeman@clearpointhealth.com.
More Posts
TLS VP, Castle, Earns Elite DEI Certification
Thought Leader Select’s Vice President of Marketing & Strategy, Brian Castle has earned certification at the highest level for professionals and executives in the practice
TLS Names Meade, Hanson, and Nufire to Research Leadership Positions
After closing out a prolific 2022, Thought Leaders Select is proud to announce a trio of colleagues taking on leadership roles with the company’s research
How is the Role of a Thought Leader in Healthcare Changing?
By Paul Meade, Patient Engagement Lead For many decades, the healthcare thought Leader, also known as a key opinion leader (KOL), or key external expert
The MSL Playbook for Creating Value
By Mark Schoeman, General Manager Prior to and over the course of the pandemic, assessments have shown that scores for MSL teams have remained consistent.
Share:
Send Us A Message